Author | Edward B. Garon, MD, MS | OncLive

Author | Edward B. Garon, MD, MS


Dr. Garon on the KEYNOTE-001 Study in NSCLC

July 24, 2019


Edward B. Garon, MD, MS, discusses the KEYNOTE-001 study, which examined the 5-year long-term overall survival in patients with non–small cell lung cancer treated with pembrolizumab.

Pembrolizumab Emerges as a Potent Treatment in NSCLC

February 11, 2016


The role of immunotherapy is emerging as an effective, and in some cases, dramatic treatment in the non-small cell lung cancer landscape.